Records 1 - 6
| PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus.
BMC medical genomics 2021 Nov 14 (1): 267.
Wang Tao, Song Jin-Fang, Zhou Xue-Yan, Li Cheng-Lin, Yin Xiao-Xing, Lu Qi
| PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adults.
Gene 2016 Feb .
Tang Lizhi, Lü Qingguo, Cao Hongyi, Yang Qiu, Tong Nanw
| Genetic variants of peroxisome proliferator-activated receptor d are associated with gastric cancer.
Digestive diseases and sciences 2013 Aug .
Jeon C, Chang SC, Mu L, Zhao J, Rao JY, Lu QY, Zhang ZF
| Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study.
The Journal of clinical endocrinology and metabolism 2008 Apr 93 (4): 1497-500.
Thamer Claus, Machann Jürgen, Stefan Norbert, Schäfer Silke A, Machicao Fausto, Staiger Harald, Laakso Markku, Böttcher Michael, Claussen Claus, Schick Fritz, Fritsche Andreas, Haring Hans-Ulri
| Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.
Diabetologia 2007 Jun 50 (6): 1201-8.
Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen
| Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects.
Diabetic medicine : a journal of the British Diabetic Association 2006 Dec 23 (12): 1307-12.
Hu C, Jia W, Fang Q, Zhang R, Wang C, Lu J, Xiang